When does Global Cord Blood Corporation (CO) report earnings?
Global Cord Blood Corporation (CO) will report earnings on 2022-10-11, after the market close.
Global Cord Blood Corporation (CO) Forecast, Price Target & Analyst Ratings
NYSE:CO • KYG393421030
Current stock price
2.9876 USD
+0.77 (+34.58%)
At close:
2.925 USD
-0.06 (-2.1%)
Pre-Market:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Global Cord Blood Corporation (CO).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $2.99 to mean target of $0.00, Based on 9 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
CO was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CO.
In the previous month the buy percentage consensus was at a similar level.
CO was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Oct 11, 2022
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.222B 23.78% | 1.16B -5.06% | 1.243B 7.21% | |
| EBITDA YoY % growth | 608.4M 40.18% | 593.96M -2.37% | 656.787M 10.58% | |
| EBIT YoY % growth | 559M 46.45% | 544.87M -2.53% | 608.865M 11.75% | |
| Operating Margin | 45.76% | 46.99% | 48.97% | |
| EPS YoY % growth | N/A 63.93% | N/A -15.16% | N/A |
All data in CNY
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CNY
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
Global Cord Blood Corporation / CO Forecast FAQ
What is the consensus rating for CO stock?
The consensus rating for Global Cord Blood Corporation (CO) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.